Andy Hartman is the Director of Corporate Quality and Compliance at Horizon Therapeutics and his group is specifically focused on oversight of Horizon’s clinical development and LCM development products/projects. Andy has held roles of increasing responsibility in sponsor organizations in Quality Control, Regulatory CMC, and Quality Assurance. His experiences have included work on pre-clinical candidates, product launches, products marketed for greater than 30 years, and everything in between.
Andy Hartman
